| 000 | 00000cam 2200000zi 4500 |
| 001 | 9.965445 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20260924111638 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 260826s2025 onca os f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 045 | |ay1y2 |
|---|
| 086 | 1 |aH82-60/2025E-PDF |
|---|
| 245 | 00|aBiosimilars in Canada : |bpolicies to promote switching and what it means for payers. |
|---|
| 264 | 1|a[Ottawa] : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c[2025] |
|---|
| 300 | |a1 online resource (11 pages) : |bcolour illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Les médicaments biosimilaires au Canada : politiques visant à favoriser la substitution et ce qu'elles signifient pour les payeurs. |
|---|
| 500 | |a"Presentation to the 2025 Annual CAHSPR Conference, May 2025." |
|---|
| 500 | |a"Presented by: Yvonne Zhang, Senior Economist." |
|---|
| 500 | |a"NPDUIS Research Initiative, Patented Medicine Prices Review Board." |
|---|
| 650 | 0|aBiosimilars|zCanada|vStatistics. |
|---|
| 650 | 0|aBiologicals|zCanada|vStatistics. |
|---|
| 650 | 0|aPharmaceutical industry|zCanada|vStatistics. |
|---|
| 655 | 7|aStatistics|2lcgft |
|---|
| 700 | 1 |aZhang, Yvonne. |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body. |
|---|
| 775 | 08|tLes médicaments biosimilaires au Canada : |w(CaOODSP)9.966216 |
|---|
| 856 | 40|qPDF|s231 KB|uhttps://publications.gc.ca/collections/collection_2026/cepmb-pmprb/H82-60-2025-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/slide-presentations/cahspr2025-biosimilars.html |
|---|